Covestor’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-447
Closed -$5K 2858
2024
Q4
$5K Buy
447
+1
+0.2% +$11 ﹤0.01% 1738
2024
Q3
$5K Sell
446
-601
-57% -$6.03K ﹤0.01% 1736
2024
Q2
$7K Sell
1,047
-1
-0.1% -$8 ﹤0.01% 1737
2024
Q1
$7K Buy
1,048
+8
+0.8% +$55 ﹤0.01% 1759
2023
Q4
$7K Buy
1,040
+1,033
+14,757% +$6.66K ﹤0.01% 1738
2023
Q3
$0 Sell
7
-1
-13% -$12 ﹤0.01% 2825
2023
Q2
$0 Hold
8
﹤0.01% 2768
2023
Q1
$0 Hold
8
﹤0.01% 2698
2022
Q4
$0 Sell
8
-1
-11% -$15 ﹤0.01% 2720
2022
Q3
$0 Sell
9
-5
-36% -$91 ﹤0.01% 2734
2022
Q2
$0 Sell
14
-800
-98% -$11.8K ﹤0.01% 2454
2022
Q1
$17K Sell
814
-55
-6% -$1.12K 0.01% 1118
2021
Q4
$25K Buy
+869
New +$24.9K 0.04% 807

Other funds holding CDMO

Covestor's CDMO Position: Q1 2025 in Review

Covestor sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 447 shares — an estimated $5K sold.

Covestor first reported a position in CDMO in Q4 2021 and held it in 13 quarters. The position peaked at $25K in Q4 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Covestor reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Covestor sold 447 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $5K.
  • Covestor first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2021 and held it in 13 quarters.
  • Covestor's Avid Bioservices, Inc. Common Stock position peaked at $25K in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Covestor's 13F filing for Q1 2025, filed 12 May 2025.